Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Two dietary 90 -day studies are available, one in rats and one in dogs.

Key value for chemical safety assessment

Toxic effect type:
dose-dependent

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
NOAEL
627 mg/kg bw/day
Study duration:
subchronic
Species:
rat

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

In a subchronic study in rats, a NOAEL of 627 mg piperazine base/kg bw/day has been established based on reduced body weight gain observed at the next higher level tested. In a subchronic study in dogs the NOAEL was set at the highest level tested as no treatment-related changes were observed; this NOAEL was at least 25 mg piperazine base/kg bw/day during the first 5 weeks of the study, and at least 60 mg/kg bw/day during week 6 -13 of the study.

Justification for classification or non-classification

In view of the NOAEL of 627 mg piperazine base/kg bw/day in rats and the NOAEL of at least 25/60 mg piperazine base/kg bw/day in dogs in 90 -day studies, there is no need to classify piperazine for STOT Repeated Exposure.